Nano, Marvin .

HRN: 29-39-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/29/2026
08/05/2026
IV
4.5G
Q6H
SEPSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: